Nothing Special   »   [go: up one dir, main page]

IN2014DN06792A - - Google Patents

Info

Publication number
IN2014DN06792A
IN2014DN06792A IN6792DEN2014A IN2014DN06792A IN 2014DN06792 A IN2014DN06792 A IN 2014DN06792A IN 6792DEN2014 A IN6792DEN2014 A IN 6792DEN2014A IN 2014DN06792 A IN2014DN06792 A IN 2014DN06792A
Authority
IN
India
Prior art keywords
metalloenzymes
mediated
symptoms
methods
instant invention
Prior art date
Application number
Other languages
English (en)
Inventor
William J Hoekstra
Robert J Schotzinger
Stephen W Rafferty
Original Assignee
Viamet Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viamet Pharmaceuticals Inc filed Critical Viamet Pharmaceuticals Inc
Publication of IN2014DN06792A publication Critical patent/IN2014DN06792A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0073Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN6792DEN2014 2012-01-20 2013-01-18 IN2014DN06792A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261589076P 2012-01-20 2012-01-20
PCT/US2013/022313 WO2013109998A1 (fr) 2012-01-20 2013-01-18 Composés inhibiteurs de métalloenzymes

Publications (1)

Publication Number Publication Date
IN2014DN06792A true IN2014DN06792A (fr) 2015-05-22

Family

ID=48799718

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6792DEN2014 IN2014DN06792A (fr) 2012-01-20 2013-01-18

Country Status (14)

Country Link
US (3) US10221160B2 (fr)
EP (1) EP2804858B1 (fr)
JP (1) JP6189865B2 (fr)
KR (1) KR102061137B1 (fr)
CN (1) CN104136427B (fr)
AU (2) AU2013209516A1 (fr)
BR (1) BR112014017751B1 (fr)
CA (1) CA2861339C (fr)
DK (1) DK2804858T3 (fr)
EA (1) EA026209B1 (fr)
ES (1) ES2774267T3 (fr)
IN (1) IN2014DN06792A (fr)
PL (1) PL2804858T3 (fr)
WO (1) WO2013109998A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013015160A (es) * 2011-06-19 2015-01-14 Viamet Pharmaceuticals Inc Compuestos inhibidores de metaloenzima.
CN104136427B (zh) * 2012-01-20 2017-03-01 威尔金制药有限公司 金属酶抑制剂化合物
MX371291B (es) 2014-03-19 2020-01-24 Viamet Pharmaceuticals Nc Inc 2-(2,4-difluorofenil)-1,1-difluoro-1-(5-sustituido-piridin-2-il)- 3-(1h-tetrazol-1-il)propan-2-oles y procedimientos para su preparacion.
CA2942982C (fr) 2014-03-19 2023-09-19 Viamet Pharmaceuticals, Inc. 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substitution-pyridine-2-yl)-3-(1h-tetrazol-1-yl)propane-2-oles et procedes de preparation correspondants
WO2015143142A1 (fr) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Préparation d'un composé antifongique
WO2015143154A1 (fr) * 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Procédé associé à un composé antifongique
WO2015143162A1 (fr) * 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Procédé de préparation d'un composé antifongique
US10000465B2 (en) 2014-03-19 2018-06-19 Mycovia Pharmaceuticals, Inc. Antifungal compound process
AU2015231238B2 (en) 2014-03-19 2019-04-04 Mycovia Pharmaceuticals, Inc. Antifungal compound process
JP2017512777A (ja) * 2014-03-19 2017-05-25 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
CA2942936A1 (fr) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Procede de preparation d'un compose antifongique
PL3119745T3 (pl) 2014-03-19 2021-01-25 Mycovia Pharmaceuticals, Inc. Sposób wytwarzania związku przeciwgrzybiczego
LT3271347T (lt) * 2015-03-19 2022-10-10 Mycovia Pharmaceuticals, Inc. Priešgrybeliniai junginiai ir jų gamybos būdai
US10308632B2 (en) 2015-09-18 2019-06-04 Vps-3, Inc. Antifungal compounds and processes for making
WO2017117393A1 (fr) 2015-12-30 2017-07-06 Viamet Pharmaceuticals, Inc. Composés inhibiteurs de métallo-enzymes
MY197478A (en) 2016-12-22 2023-06-19 Calithera Biosciences Inc Compositions and methods for inhibiting arginase activity
CN109666019B (zh) * 2017-10-14 2021-04-06 朱允涛 一种氘代的氮唑醇类化合物及其制备方法和用途
CN109810049B (zh) * 2018-11-30 2021-01-15 深圳大学 一种含吡啶的化合物及其提取方法
TW202140445A (zh) * 2020-01-17 2021-11-01 大陸商上海森輝醫藥有限公司 四氮唑類化合物的可藥用鹽及其結晶形式、製備方法和用途

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8304282D0 (en) * 1983-02-16 1983-03-23 Pfizer Ltd Antifungal agents
GB8305377D0 (en) 1983-02-25 1983-03-30 Pfizer Ltd Antifungal agents
US5087240A (en) 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
US4921475A (en) 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
AU4327585A (en) 1984-06-21 1986-01-02 Imperial Chemical Industries Plc Antifungal azole compounds
GB8415889D0 (en) 1984-06-21 1984-07-25 Ici Plc Antifungal azole compounds
US4738851A (en) 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
US5163899A (en) 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
GB8804164D0 (en) 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US4882150A (en) 1988-06-03 1989-11-21 Kaufman Herbert E Drug delivery system
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US5521222A (en) 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
PT96059B (pt) 1989-12-04 1998-07-31 Searle & Co Sistema de camada unica para a administracao de um medicamento por via transdermica
US5077033A (en) 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
DE69212850T2 (de) 1991-01-15 1997-03-06 Alcon Lab Inc Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen
US5352456A (en) 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
GB9121456D0 (en) * 1991-10-10 1991-11-27 Pfizer Ltd Triazole antifungal agents
WO1993011938A1 (fr) 1991-12-18 1993-06-24 Minnesota Mining And Manufacturing Company Structures d'arret stratifiees
EP0553769B1 (fr) 1992-01-29 1996-01-03 FRANZ VÖLKL GmbH & CO. SKI UND TENNIS SPORTARTIKELFABRIK KG Raquette, en particulier raquette de tennis
US5358939A (en) 1992-06-25 1994-10-25 Rohm And Haas Company Fungicidal 2-aryl-2,2-disubstituted ethyl-1,2,4-triazoles
IL114193A (en) 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
MY115814A (en) 1995-06-16 2003-09-30 Bayer Ip Gmbh Crop protection compositions
GB9512961D0 (en) 1995-06-26 1995-08-30 Pfizer Ltd Antifungal agents
GB9602080D0 (en) 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
IT1283911B1 (it) 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6197934B1 (en) 1998-05-22 2001-03-06 Collagenesis, Inc. Compound delivery using rapidly dissolving collagen film
JP2000344744A (ja) 1999-06-04 2000-12-12 Ss Pharmaceut Co Ltd アセトフェノン誘導体およびその製法
US6362172B2 (en) 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
KR100959404B1 (ko) 2006-10-18 2010-05-25 이인환 치아 근관충전용 근관치료기 및 그의 발열팁
WO2008064311A2 (fr) 2006-11-21 2008-05-29 Viamet Pharmaceuticals, Inc. Inhibiteurs de la métallo-oxydoréductase faisant appel à des fractions se liant aux métaux en combinaison avec des fractions de ciblage
US8221057B2 (en) 2008-06-25 2012-07-17 General Electric Company Method, system and controller for establishing a wheel space temperature alarm in a turbomachine
JP2012501979A (ja) 2008-09-03 2012-01-26 バイエル・クロップサイエンス・アーゲー ある種のさび菌を防除するための殺真菌性化合物組成物の使用
EP2519508B1 (fr) * 2009-12-31 2014-07-02 Viamet Pharmaceuticals, Inc. Composés inhibiteurs de métallo-enzyme
EP2563771B1 (fr) * 2010-04-24 2015-11-25 Viamet Pharmaceuticals, Inc. Composés inhibiteurs de métalloenzyme
AU2011320565A1 (en) * 2010-10-28 2013-05-23 Innocrin Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
PT2638021T (pt) * 2010-11-13 2019-01-10 Innocrin Pharmaceuticals Inc 1-(6,7-bis(difluorometoxi)naftalen-2-il)-2-metil-1-(1h-1,2,3-triazol-4-il)propan-1-ol como inibidor de cyp17 para o tratamento de doenças dependentes de andrógeno, doenças tais como o cancro da próstata
BR112013014484A2 (pt) * 2010-12-13 2016-07-19 Viamet Pharmaceuticals Inc compostos inibidores de metaloenzimas
MX2013015160A (es) * 2011-06-19 2015-01-14 Viamet Pharmaceuticals Inc Compuestos inhibidores de metaloenzima.
CA2838912C (fr) * 2011-06-19 2019-11-26 Viamet Pharmaceuticals, Inc. Composes inhibiteurs de metalloenzymes
MX2013015159A (es) * 2011-06-23 2015-01-14 Viamet Pharmaceuticals Inc Compuestos inhibidores de metaloenzima.
CA2846117A1 (fr) * 2011-08-30 2013-03-07 Viamet Pharmaceuticals, Inc. Composes inhibiteurs de metalloenzyme
EP2788343B1 (fr) * 2011-12-11 2018-02-28 Viamet Pharmaceuticals (NC), Inc. Composés inhibiteurs de métalloenzymes
CN104136427B (zh) * 2012-01-20 2017-03-01 威尔金制药有限公司 金属酶抑制剂化合物
IN2014DN06812A (fr) 2012-01-20 2015-05-22 Viamet Pharmaceuticals Inc
WO2014117090A1 (fr) * 2013-01-28 2014-07-31 Viamet Pharmaceuticals, Inc. Composés inhibiteurs de métalloenzyme
CA2915054A1 (fr) * 2013-06-12 2014-12-18 Viamet Pharmaceuticals, Inc. Composes inhibiteurs de metallo-enzymes
KR20160144410A (ko) * 2014-04-15 2016-12-16 다우 아그로사이언시즈 엘엘씨 살진균제로서의 금속효소 억제제 화합물
JP6532480B2 (ja) * 2014-04-15 2019-06-19 ダウ アグロサイエンシィズ エルエルシー 殺真菌剤としての金属酵素阻害剤化合物
EP4311577A3 (fr) * 2016-12-29 2024-04-17 Ji Xing Pharmaceuticals Hong Kong Limited Composés inhibiteurs de métalloenzymes

Also Published As

Publication number Publication date
EP2804858A4 (fr) 2015-07-29
US20190169159A1 (en) 2019-06-06
CN104136427A (zh) 2014-11-05
JP6189865B2 (ja) 2017-08-30
WO2013109998A1 (fr) 2013-07-25
BR112014017751B1 (pt) 2021-12-07
US11247981B2 (en) 2022-02-15
US10526312B2 (en) 2020-01-07
KR102061137B1 (ko) 2019-12-31
PL2804858T3 (pl) 2020-06-29
EP2804858B1 (fr) 2019-12-25
KR20140116939A (ko) 2014-10-06
US20200247779A1 (en) 2020-08-06
EA026209B1 (ru) 2017-03-31
US20150004666A1 (en) 2015-01-01
DK2804858T3 (da) 2020-03-16
US10221160B2 (en) 2019-03-05
CA2861339C (fr) 2020-08-25
AU2013209516A1 (en) 2014-08-28
EP2804858A1 (fr) 2014-11-26
ES2774267T3 (es) 2020-07-20
CA2861339A1 (fr) 2013-07-25
AU2017232080B2 (en) 2019-02-14
EA201491385A1 (ru) 2015-02-27
JP2015504095A (ja) 2015-02-05
AU2017232080A1 (en) 2017-10-12
CN104136427B (zh) 2017-03-01
BR112014017751A8 (pt) 2021-03-09

Similar Documents

Publication Publication Date Title
IN2014DN00288A (fr)
IN2014DN00286A (fr)
IN2014MN00093A (fr)
IN2014MN01378A (fr)
IN2014DN06792A (fr)
WO2011133875A3 (fr) Composés inhibiteurs de métalloenzyme
MX2018008105A (es) Compuestos inhibidores de metaloenzima.
EA201690007A1 (ru) Соединения, ингибирующие металлоферменты
GB201103062D0 (en) Method
WO2012064943A3 (fr) Composés inhibiteurs de métalloenzymes
PH12015500525A1 (en) Formulations of enzalutamide
UY36080A (es) Compuestos inhibidores de metaloenzima como fungicidas.
WO2011082245A3 (fr) Composés inhibiteurs de métallo-enzyme
MX2022012386A (es) Compuestos inhibidores de metaloenzimas.
WO2012058529A3 (fr) Composés inhibiteurs de métalloenzymes
UY36081A (es) Compuestos inhibidores de metaloenzima como fungicidas.
WO2012082746A3 (fr) Composés inhibiteurs de métalloenzyme
WO2013033004A3 (fr) Composés inhibiteurs de métalloenzyme
WO2018125799A3 (fr) Composés inhibiteurs des métalloenzymes
PH12016500824A1 (en) Compositions and methods for the treatment of viral diseases with pde4 modulators